{"id":172973,"date":"2025-12-10T03:49:17","date_gmt":"2025-12-10T08:49:17","guid":{"rendered":"https:\/\/old.alphastreet.com\/india\/?p=172973"},"modified":"2025-12-10T03:49:17","modified_gmt":"2025-12-10T08:49:17","slug":"alembic-pharmaceuticals-q2-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-q2-fy26-earnings-results\/","title":{"rendered":"Alembic Pharmaceuticals Q2 FY26 Earnings Results"},"content":{"rendered":"<p>Alembic Pharmaceuticals Ltd, engaged in development, manufacturing, and marketing of formulations and APIs with 3 R&amp;D and 5 manufacturing facilities, posted robust earnings growth in Q2FY26.<\/p>\n<h2>Financial Highlights:<\/h2>\n<ul>\n<li>Revenues increased 15.9% year-on-year to \u20b91,910 crore from \u20b91,648 crore, led by strong growth in US generics, ex\u2011US markets, and APIs.<\/li>\n<li>Total expenses rose 13.01% to \u20b91,694 crore from \u20b91,499 crore, growing slower than revenues and supporting operating leverage. \u200b<\/li>\n<li>Consolidated net <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/61b69ed5-405a-4863-8aa0-4e2b2b983e92.pdf\" target=\"_blank\" rel=\"noopener\">profit<\/a> grew 20.26% to \u20b9184 crore from \u20b9153 crore, with EBITDA up sharply and margins improving. \u200b<\/li>\n<li>Earnings per share improved 20.51% to \u20b99.40 from \u20b97.80.<\/li>\n<\/ul>\n<h2>Outlook:<\/h2>\n<p>Alembic Pharmaceuticals Ltd aims to sustain growth via new product launches in regulated markets, API capacity expansion, and continued investment in R&amp;D to support a healthy pipeline. \u200b<\/p>\n<p>Explore the company\u2019s past earnings and latest concall transcripts, <a href=\"https:\/\/alphastreet.com\/india\/symbol\/aplltd\/\">click here<\/a> to visit the AlphaStreet India News Channel.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-172974\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AP.png\" alt=\"Q2 FY26\" width=\"1489\" height=\"1817\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alembic Pharmaceuticals Ltd, engaged in development, manufacturing, and marketing of formulations and APIs with 3 R&amp;D and 5 manufacturing facilities, posted robust earnings growth in Q2FY26. Financial Highlights: Revenues increased 15.9% year-on-year to \u20b91,910 crore from \u20b91,648 crore, led by strong growth in US generics, ex\u2011US markets, and APIs. Total expenses rose 13.01% to \u20b91,694 [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":172974,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[11080],"class_list":["post-172973","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-formulations"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":169930,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-q1-fy26-earnings-results-revenue-up-10-net-profit-rises-14-yoy\/","url_meta":{"origin":172973,"position":0},"title":"Alembic Pharmaceuticals Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 8, 2025","format":false,"excerpt":"Alembic Pharmaceuticals Limited is a leading player in the pharmaceutical industry, engaged in the development, manufacturing, and marketing of formulations and active pharmaceutical ingredients (APIs). The company operates 3 R&D centers and 5 advanced manufacturing facilities, supporting global exports and a robust domestic presence. Presenting below are its Q1 FY26\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"APLLTD Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147370,"url":"https:\/\/alphastreet.com\/india\/earnings-alembic-pharmaceuticals-limited-nse-aplltd-q4fy23-results-out-total-income-fell-1-yoy\/","url_meta":{"origin":172973,"position":1},"title":"Earnings | Alembic Pharmaceuticals Limited (NSE: APLLTD): Q4FY23 Results Out; Total Income fell 1% YoY.","author":"Divyansh_Kasana","date":"May 26, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is a leading player in the pharmaceutical industry, specializing in the development, manufacturing, and marketing of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). The company boasts three research and development (R&D) facilities dedicated to innovative drug development and technological advancements. With a strong focus on quality\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165765,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q2fy25-12-rise-in-profits\/","url_meta":{"origin":172973,"position":2},"title":"Alembic Pharmaceuticals Ltd Q2FY25; 12% rise in Profits","author":"Divyansh_Kasana","date":"November 21, 2024","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q2FY25 of \u20b91,648.00 Crores up from \u20b91,595.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168418,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q4fy25-12-fall-in-profits\/","url_meta":{"origin":172973,"position":3},"title":"Alembic Pharmaceuticals Ltd Q4FY25; 12% fall in Profits","author":"Divyansh_Kasana","date":"May 19, 2025","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b91,770.00 Crores up from \u20b91,517.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167021,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q3fy25-23-fall-in-profits\/","url_meta":{"origin":172973,"position":4},"title":"Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits","author":"Divyansh_Kasana","date":"February 21, 2025","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b91,693.00 Crores up from \u20b91,631.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151180,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q1fy24-18-rise-in-revenue\/","url_meta":{"origin":172973,"position":5},"title":"Alembic Pharmaceuticals Ltd Q1FY24; 18% rise in Revenue.","author":"Divyansh_Kasana","date":"August 4, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b91,486.00 Crores up from \u20b91,262.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-168.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/172973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=172973"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/172973\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=172973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=172973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=172973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}